Article
Pharmacological inhibition of GPR4 remediates intestinal inflammation in a mouse colitis model
2019-01-29
Abstract excerpt
Inflammatory bowel disease (IBD) is characterized by chronic, recurring inflammation of the digestive tract. Current therapeutic approaches are limited and include biologics and steroids such as anti-TNFα monoclonal antibodies and corticosteroids, respectively. Significant adverse drug effects can occur for chronic usage and include increased risk of infection in some patients. GPR4, a pH-sensing G protein-coupled...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 32c0fe2e-ad69-5551-8211-772bdf0fcbc6
- DOI
- 10.1101/533174
